CCMH
EPZM

Cornerstone Capital Management Holdings’s Epizyme, Inc EPZM Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-8,103
Closed -$152K – 1501
2015
Q1 		$152K Sell
8,103
-43,697
-84% -$902K ﹤0.01% 1217
2014
Q4 		$977K Buy
51,800
+27,400
+112% +$640K 0.01% 888
2014
Q3 		$661K Buy
+24,400
New +$758K 0.01% 934

Other funds holding EPZM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Cornerstone Capital Management Holdings's EPZM Position: Q2 2015 in Review

Cornerstone Capital Management Holdings sold out of Epizyme, Inc (EPZM) in Q2 2015, closing a stake of 8,103 shares — an estimated $152K sold.

Cornerstone Capital Management Holdings first reported a position in EPZM in Q3 2014 and held it in 3 quarters. The position peaked at $977K in Q4 2014. 95 funds tracked by Wall St. Rank hold EPZM as of Q2 2015.

  • Cornerstone Capital Management Holdings reported no remaining Epizyme, Inc position as of Q2 2015 after selling out during the quarter.
  • Cornerstone Capital Management Holdings sold 8,103 Epizyme, Inc shares in Q2 2015, an estimated $152K.
  • Cornerstone Capital Management Holdings first reported a position in Epizyme, Inc in Q3 2014 and held it in 3 quarters.
  • Cornerstone Capital Management Holdings's Epizyme, Inc position peaked at $977K in Q4 2014.
  • 95 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2015.

Based on Cornerstone Capital Management Holdings's 13F filing for Q2 2015, filed 11 Aug 2015.